Kate Haviland
CIK 1663022 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
54
Lifetime Open-Market Net
-$13.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-16 | BCAX | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | FULC | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −12,464 | -$1.13M | EDGAR |
| 2024-03-06 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-06-29 | FULC | Grant (A) | — | $0 | EDGAR |
| 2023-03-08 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −6,640 | -$303.4K | EDGAR |
| 2023-03-03 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2022-11-07 | Blueprint Medicines Corp (BPMC) Delisted | Buy (P) | +1,100 | $48.4K | EDGAR |
| 2022-06-29 | FULC | Grant (A) | — | $0 | EDGAR |
| 2022-03-08 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −2,767 | -$162.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.